Directors

Graham Cooley, Chief Executive Officer, has transferred in 37 shares in the company on the 14th July 2021 at a price of £0.00. The Director...

Graham Cooley, Chief Executive Officer, bought 37 shares in the company on the 14th July 2021 at a price of £4.06. The Director now holds...

Salt Lake Potash Limited has appointed Stuart Fraser as chief financial officer, assuming all responsibilities from acting CFO Grant Coyle.

Mr Coyle has accepted...

Gene and cell therapy group Oxford Biomedica has named Dr Michael Hayden as a non-executive director, effective from July 15.

Dr Hayden joins the...

Richard Steele, Financial Director, sold post-exercise 9,921 shares in the company on the 14th July 2021 at a price of £1.90. The Director now holds...

Christopher Pitman, Chairman, received via a placing 2,000,000 shares in the company on the 14th July 2021 at a price of £0.01. The Director now...

Martin Lampshire, Non Executive Director, received via a placing 2,000,000 shares in the company on the 14th July 2021 at a price of £0.01. The...

William James, Chairman, sold 20,000,000 shares in the company on the 14th July 2021 at a price of £0.01.

Director deals data provided by ...

William James, Chairman, bought 20,000,000 shares in the company on the 14th July 2021 at a price of £0.01. The Director now holds 20,000,000 shares....

Matthew Royde, Non Executive Director, bought 53,000 shares in the company on the 9th July 2021 at a price of £1.24. The Director now holds...